Founded in 2002
by experienced industry executives, Proreo Pharma
is a privately owned Swiss based specialty pharmaceutical
company.
With emphasis on the therapeutic areas of central
nervous system, gastroenterology, rheumatology,
renal care, and surgery, Proreo Pharma focuses on
the acquisition, development, and commercialization
of innovative specialist medicines.
In Switzerland, France and Germany, the company
uses its own commercial infrastructure to market
its products. Further presence and reach is achieved
via a network of distribution partners.
In the United Kingdom, Proreo Pharma together
with Nespera Ltd (Israel/Cyprus) has established
a joint venture company called Prospera Pharma
Ltd, which is dedicated to the development of
several novel products in the field of pulmonary
hypertension and cognitive, muscular and
endocrine disorders. |
NEWS
3 Sept.2009
Proreo Pharma sets up German business operation
press release
18 Dec.2008
Proreo Pharma and Nespera set up joint venture company
Prospera Pharma
press release
7 Feb.2007
Speciality European
Pharma Ltd acquires Proreo Pharma International
AG - Proreo Pharma AG unaffected by transaction
press release
|
